Advaxis, Inc. Purchase Agreements
12 Contracts & Agreements
- Asset Purchase Agreement, dated as of February 5, 2024, by and between Ayala Pharmaceuticals, Inc. and Immunome, Inc (Filed With SEC on February 6, 2024)
- Form of Securities Purchase Agreement between Advaxis, Inc. and the investors thereto, dated January 27, 2022 (Filed With SEC on January 28, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on November 9, 2021)
- Securities Purchase Agreement dated April 12, 2021, by and among Advaxis, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on April 12, 2021)
- Purchase Agreement, dated July 30, 2020, by and between Advaxis, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 3, 2020)
- Securities Purchase Agreement dated January 21, 2020, by and among Advaxis, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on January 23, 2020)
- SECURITIES PURCHASE AGREEMENT DOCUMENT SPA-08282013 (Filed With SEC on September 10, 2013)
- Form Of Securities Purchase Agreement (Filed With SEC on March 25, 2013)
- Principal Amount: ___________Purchase Price: ___________Issue Date: October 31, 2011Maturity Date: October 31, 2012 (Filed With SEC on November 2, 2011)
- FORM OFSTOCK PURCHASE AGREEMENT (Filed With SEC on May 14, 2010)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 8, 2006)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 18, 2005)
